Header

UZH-Logo

Maintenance Infos

Management of neoplastic meningitis


Roth, P; Weller, M (2015). Management of neoplastic meningitis. Chinese Clinical Oncology, 4(2):26.

Abstract

Leptomeningeal dissemination of tumor cells, also referred to as neoplastic meningitis, is most frequently seen in patients with late-stage cancer and mostly associated with a poor prognosis. Basically, neoplastic meningitis may affect all patients with a malignant tumor but is most common in patients affected by lung cancer, breast carcinoma, melanoma or hematologic neoplasms such as lymphoma and leukemia. Controlled clinical trials are largely lacking which results in various non-standardized treatment regimens. The presence of solid tumor manifestations in the CNS as well as the extracranial tumor load defines the most appropriate treatment approach. Radiation therapy, systemic chemotherapy and intrathecal treatment must be considered. For each patient, the individual situation needs to be carefully evaluated to determine the potential benefit as well as putative side effects associated with any therapy. A moderate survival benefit and particularly relief from pain and neurological deficits are the main treatment goals. Here, we summarize the management of patients with neoplastic meningitis and review the available treatment options.

Abstract

Leptomeningeal dissemination of tumor cells, also referred to as neoplastic meningitis, is most frequently seen in patients with late-stage cancer and mostly associated with a poor prognosis. Basically, neoplastic meningitis may affect all patients with a malignant tumor but is most common in patients affected by lung cancer, breast carcinoma, melanoma or hematologic neoplasms such as lymphoma and leukemia. Controlled clinical trials are largely lacking which results in various non-standardized treatment regimens. The presence of solid tumor manifestations in the CNS as well as the extracranial tumor load defines the most appropriate treatment approach. Radiation therapy, systemic chemotherapy and intrathecal treatment must be considered. For each patient, the individual situation needs to be carefully evaluated to determine the potential benefit as well as putative side effects associated with any therapy. A moderate survival benefit and particularly relief from pain and neurological deficits are the main treatment goals. Here, we summarize the management of patients with neoplastic meningitis and review the available treatment options.

Statistics

Citations

6 citations in Web of Science®
6 citations in Scopus®
Google Scholar™

Altmetrics

Downloads

29 downloads since deposited on 04 Dec 2015
18 downloads since 12 months
Detailed statistics

Additional indexing

Item Type:Journal Article, refereed, further contribution
Communities & Collections:04 Faculty of Medicine > University Hospital Zurich > Clinic for Neurology
Dewey Decimal Classification:610 Medicine & health
Language:English
Date:June 2015
Deposited On:04 Dec 2015 10:55
Last Modified:08 Dec 2017 14:49
Publisher:AME Publishing Company
ISSN:2304-3865
Free access at:Publisher DOI. An embargo period may apply.
Publisher DOI:https://doi.org/10.3978/j.issn.2304-3865.2015.05.02
Official URL:http://www.thecco.net/article/view/6650/7460
PubMed ID:26112812

Download

Download PDF  'Management of neoplastic meningitis'.
Preview
Content: Accepted Version
Filetype: PDF
Size: 91kB
View at publisher
Download PDF  'Management of neoplastic meningitis'.
Preview
Content: Published Version
Filetype: PDF
Size: 398kB